Kexing Biopharm Co.,Ltd.

About Kexing Biopharm Co.,Ltd.

Kexing Biopharm integrates R&D, manufacture, and sales of biopharmaceuticals. 
Its production site offers Recombinant Human Erythropoietin Injection(EPO), Recombinant Human Granulocyte Colony-stimulating Factor Injection(rh-G-CSF)Filgrastim, and Combined Clostridium Butyricum and Bifidobacterium Powders, Live for clinical and commercial use. 
The company develops recombinant genetic biological drugs and micro-ecological preparation, to serve the clinical treatment needs of kidney diseases, tumor, and gastrointestin...

  • CN
  • 2022
    On CPHI since
  • 500 - 999
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
Meet us at

CPHI Japan 2024

East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
17 Apr 2024 – 19 Apr 2024

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 - 21 June 2024